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Abstract
Gold nanoclusters are small (1–3 nm) nanoparticles with a high surface area that are useful for biomedical studies and drug
delivery. The synthesis of small, surface-functionalized gold nanoclusters is greatly dependent on the reaction conditions. Here, we
describe a straightforward, efficient and robust room temperature one-pot synthesis of 2 nm gold nanoclusters using thioglucose as
a reducing and stabilizing agent, which was discovered by serendipity. The resultant monodisperse gold nanoclusters are more
stable than those generated using some other common methods. The carboxylic acid contained in the stabilizing agent on the cluster
surface serves as anchor for nanocluster functionalization. Alternatively, the addition of thiols serves to functionalize the nanoclus-
ters. The resulting non-cytotoxic nanoclusters are taken up by cells and constitute a tuneable platform for biomedical applications
including drug delivery.
Findings
Nanoparticles ranging in size from 1 to 100 nm are ideal tools
to study biological processes [1,2]. Many different materials, in-
cluding gold, have been used to create nanoparticles [3-6]. Gold
nanoparticles are an attractive platform because of their bio-
compatibility, low toxicity, and low immunogenicity [7], their
inherent optoelectronic properties [8] and high transmission
electron microscopy (TEM) contrast. They are relatively easy to
synthesize, functionalize, are biocompatible and have control-
lable optical properties [3,9-12]. Therefore, gold nanoparticles
functionalized with carbohydrates [13], proteins [14], anti-
bodies [15] and DNA [16] are commonly used as multivalent
materials for biological studies. Gold nanoparticles have been
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Figure 1: A) One-pot synthesis of Glc-NCs at room temperature; B) UV–vis spectra of freshly synthesized Glc-NCs and after three days are indica-
tive of stable particles; C) high-resolution TEM bright-field image of Glc-NCs showing monodisperse nanoclusters, scale bar 2 nm; D) size distribu-
tion of 110 nanoclusters of Glc-NCs yielding diameters of 2.02 ± 0.18 nm.
used in vivo as radiotracers [15,17], for targeted delivery [18]
and, when functionalized with carboxylic acids, inhibit
β-amyloid fibril growth related to Alzheimer’s disease [19].
Gold nanoclusters (NCs) are gold nanoparticles ranging in size
between 1 and 3 nm, with interesting physicochemical proper-
ties and increased surface area for drug delivery applications
[20].
There are several methods to synthesize gold nanoparticles. In
addition to the reduction of HAuCl4 with citrate at high temper-
atures [21], sodium borohydride can act as a reducing agent
while an alkanethiol stabilizes the nanoparticles [22]. The latter
method was used to prepare glyconanoparticles by adding thiol-
terminated glycoconjugates [23]. Gold nanoparticles have also
been prepared under reflux using 1-thioglucose as reducing and
stabilizing agent [24] but the resulting nanoparticles are too
unstable to be used as biosensors [25].
In an effort to create monodisperse, stable and surface-functio-
nalized gold nanoclusters, we explored 1-thioglucose as a stabi-
lizing and reducing agent. By serendipity we discovered a novel
one-pot method to prepare gold nanoclusters using 1-thioglu-
cose at room temperature. This simple and robust synthesis
produces stable, and monodisperse nanoclusters. Oxidation of
the carbohydrate results in carboxylic acid as determined by
X-ray photoelectron spectroscopy (XPS). Coupling to the
carboxylic acids or addition of thiols functionalizes the NCs
that are taken up by cells but are less cytotoxic than NCs pre-
pared by other methods.
During experiments exploring different methods for the synthe-
sis of gold tetrapods [26], we found that simply the addition of
1-thioglucose as reducing agent to gold salts resulted in the for-
mation of monodisperse gold NCs (Figure 1A). The reaction
produced the same products at any temperature between 0 and
90 °C and thereby stood in stark contrast to all known literature
procedures [27-29] that were sensitive to all reaction conditions
including the speed of the stirrer. The influence of the gold to
1-thioglucose ratio on the yield and quality of the glucose-stabi-
lized gold nanoclusters (Glc-NCs) was determined (Table S1,
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Figure 2: A) Functionalization of Glc-NCs by coupling trifluoroethanol to the carboxylic acid groups on the surface of the nanocluster to yield Glc-
NC@F and via thio-substitution of pentylthiol mannoside on the gold surface giving Glc-NC@Man; B) 19F NMR of Glc-NC@F after dialysis showing
one product peak; C) vials containing (1) Glc-NCs (2) Glc-NC@Man (3) Glc-NCs + ConA (4) Glc-NC@Man + ConA. Aggregation is only observed
upon addition of the lectin ConA (4).
Supporting Information File 1). The nanoclusters aggregated
within 5 h at very high ratios of gold ions to 1-thioglucose
(Figure S1, Supporting Information File 1). At higher gold ion
concentrations, NCs that are not fully coated with stabilizer
aggregate. At high thioglucose concentrations, NCs do not
form. Monodisperse gold NCs (2.02 ± 0.18 nm) were obtained
as determined by high resolution TEM (Figure 1C,D) and
dynamic light scattering (DLS) (Figure S4, Supporting Informa-
tion File 1). The one-pot synthesis of Glc-NCs is independent
on the temperature between 0 and 90 °C (Figure S5, Supporting
Information File 1).
The Glc-NCs are more stable than nanoclusters that were stabi-
lized with cetyltrimethylammonium bromide (CTAB-NCs) and
tetrakis(hydroxymethyl)phosphonium chloride (THPC-NCs) as
determined by UV absorbance. Gold nanoparticles smaller than
5 nm do not display a plasmon band. The Glc-NCs are stable
and showed the same absorbance profile after three days of dial-
ysis (Figure 1B). In contrast, the CTAB-NCs and the THPC-
NCs exhibit plasmon bands (Figure S6, Supporting Informa-
tion File 1). The CTAB-NCs showed a plasmon band directly
after synthesis, which shifted to longer wavelengths after three
days, suggesting an increasing rate of aggregation. TEM images
of freshly prepared CTAB-NCs revealed polydisperse nano-
clusters in terms of both size and shape (data not shown). The
absorbance profile of THPC-NCs did not show a plasmon band
after the synthesis. However, after three days, a plasmon band
appeared, revealing particle aggregation. The surface charge did
not change upon dialysis for any sample as indicated by the zeta
potential (Figure S7, Supporting Information File 1).
To better understand the role of the stabilizing agent used to
prepare Glc-NCs, XPS was employed (Figure S8, Supporting
Information File 1). The gold core of the nanoclusters (con-
firmed by the Au 4f scan) is stabilized through an Au–S bond
(162.5 eV, S 2p scan). C–O bonds and a carbonyl group were
detected on the nanocluster surface by C 1s (286 eV and
288.5 eV, respectively) and O 1s (531.5 eV and 533 eV, respec-
tively) scans (Table S2 and Table S3, Supporting Information
File 1). The carbonyl signal likely is indicative of the oxidation
of hydroxy groups of the carbohydrate as the precursor 1-thio-
glucose contains no carbonyl group. The carboxylic acid in the
stabilizing agent was confirmed by the XPS O–C=O signal and
IR bands at 3270, 1732 and 1014 cm−1 (Figure S9, Supporting
Information File 1). To confirm the XPS and IR analyses, tri-
fluoroethanol was coupled to form Glc-NC@F to be monitored
by using 19F NMR (Figure 2A,B). The 19F NMR signal of the
starting material shifts after 30 min to show both starting mate-
rial and product peaks (Figure S10a, Supporting Information
File 1). Only the product peak remained after dialysis. Twenty
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Figure 3: Cell viability of Glc-NCs A) purified and B) without purification incubated for one day with L929 cells. The Glc-NCs were not toxic at any of
the concentrations studied. C) Cellular uptake of Glc-NCs when incubated with L929 cells for one day. Gold concentration taken up by the cells was
measured with ICP-OES and showed an uptake of 108–109 gold atoms per cell.
stabilizer molecules per nanocluster were measured by
comparing the number of trifluoroethanol molecules coupled to
Glc-NCs using an internal standard (Figure S10b, Supporting
Information File 1). Thus, we demonstrated that Glc-NCs can
be functionalized via coupling to carboxylic acid groups.
To illustrate the surface functionalization of Glc-NCs,
pentylthiol mannoside (Scheme S1, Supporting Information
File 1) was incubated with Glc-NCs overnight to yield Glc-
NC@Man (Figure 2A). After dialysis, the IR spectrum
revealed two new peaks corresponding to the C–H bonds of the
linker at 2856 and 2925 cm−1. Apparently, all carbohydrates
reacted as no S–H peaks were observed (Figure S11, Support-
ing Information File 1). Functional evidence for the formation
of Glc-NC@Man was obtained by aggregating Glc-NC@Man
with the addition of the mannose-binding lectin concanavalin A
(ConA). Unfunctionalized Glc-NCs fail to aggregate since
oxidized thio-glucose is not recognized by ConA (Figure 2C).
Glc-NC@Man are monodisperse prior to aggregation by the
addition of ConA as judged by TEM (Figure S12, Supporting
Information File 1).
Nanocluster cytotoxicity was assessed by incubating the nano-
clusters for one day with the mouse cell line L929 for a proof-
of-principle study. Cell viability was measured using the MTS
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium inner salt] assay [30]. The cyto-
toxicity of Glc-NCs, CTAB-NCs and THPC-NCs was com-
pared. CTAB-NCs were toxic even at low concentrations
(0.2–25 µM), whereas both THPC-NCs (Figure S13, Support-
ing Information File 1) and Glc-NCs did not show any toxicity
at 500 µM (Figure 3A). To test whether the free stabilizers were
affecting the cytotoxicity, both Glc-NCs and THPC-NCs were
measured after synthesis without dialysis. Glc-NCs were not
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cytotoxic at any concentration tested (Figure 3B), whereas
THPC-NCs were toxic at 100 µM (Figure S14, Supporting
Information File 1), indicating that Glc-NCs are suitable for bi-
ological experiments even without purification.
Cellular uptake of the nanoclusters was studied by incubating
12.5 and 25 µM Glc-NCs with the same cell line. After 24 h,
the cells were washed with buffer and then treated with aqua
regia to transform the gold nuclei into gold ions that were
detected by an inductively coupled plasma optical emission
spectrometer (ICP-OES). The Glc-NCs are cell permeable as
108–109 gold atoms were delivered per cell and can potentially
be used in cellular delivery applications (Figure 3C).
In summary, we developed a straightforward, robust and effi-
cient one-pot method to prepare glucose-stabilized gold nano-
clusters (Glc-NCs). The resulting 2 nm nanoclusters are
monodisperse and more stable than gold nanoclusters synthe-
sized by other methods. Functionalization of the Glc-NCs is
achieved either via coupling to the carboxylic acid of the stabi-
lizing agent or substitution with a thio-functionalized molecule.
Glc-NCs are non-toxic, but are taken up by L929 cells. Surface
functionalization of Glc-NCs with biomolecules opens opportu-
nities for drug delivery applications.
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